ArticleJournal of cosmetic dermatology2025
Dual Benefits of Calcium Hydroxyapatite Filler: A Prospective Study on Midface Volume Restoration and Skin Quality Enhancement.
Article in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Regenerative Functional Microspheres for Aesthetic Medicine: Mechanism, Materials, Fabrication, and Clinical Applications.Advanced healthcare materials · 2026Review
- Differential Modulation of Extracellular Matrix- and Longevity-Related Gene Expression by Calcium Hydroxylapatite Formulations.Life (Basel, Switzerland) · 2026Article
- The STIIM UP Protocol: Exploratory Evaluation of the Potential of Combined Calcium Hydroxyapatite, Hyaluronic Acid, and Botulinum Toxin A in Neck Rejuvenation.Journal of clinical medicine · 2026Article
- Review
- Review
- A Prospective, Open-Label, Post Marketing Study of the Safety and Effectiveness of a Hyaluronic Acid and Calcium Hydroxyapatite Hybrid Injectable.Journal of cosmetic dermatology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundCalcium hydroxyapatite (CaHA) fillers are widely used for soft-tissue augmentation due to their volumizing properties and biostimulatory effects. However, clinical evidence supporting the dual role of CaHA as both a volumizer and a skin booster remains limited.
objectivesTo evaluate the efficacy of CaHA filler (VoLassom) in midface volume restoration and assess its effects on skin barrier function, hydration, and elasticity over 24 weeks.
methodsFifteen participants aged 19-70 years with moderate midface volume deficiency (Midface Volume Deficiency Scale [MFVDS] grade ≥ 3) received CaHA filler injections. Clinical assessments included MFVDS scoring, the Global Aesthetic Improvement Scale (GAIS), and patient satisfaction ratings at baseline and at weeks 2, 4, and 24. Instrumental evaluations of transepidermal water loss (TEWL), corneometer-based hydration, and cutometer-measured elasticity (R2, R5, and R7) were conducted at all timepoints.
resultsMFVDS scores significantly decreased from baseline to weeks 2, 4, and 24, demonstrating sustained volume restoration. GAIS scores remained high, with all participants rated as significantly improved (5.0) at weeks 2 and 4, though slightly reduced at week 24 (4.53 ± 0.52). Patient satisfaction remained consistently high. TEWL significantly decreased at weeks 4 and 24 (p < 0.01), indicating improved skin barrier function. Corneometer measurements showed significant hydration improvements at all timepoints (p < 0.05 and p < 0.001, respectively). Skin elasticity, measured by R2, R5, and R7, significantly increased at weeks 4 and 24 (p < 0.01), suggesting enhanced skin firmness.
conclusionsCaHA filler demonstrated effective and sustained volume restoration while significantly improving skin hydration, barrier function, and elasticity. These findings suggest that CaHA functions not only as a volumizer but also as a skin booster, offering a comprehensive approach to facial rejuvenation. Nevertheless, further studies with larger cohorts are warranted to validate these results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.